Commentary and Analysis

Comment: Xerox forgoes courtroom reprieve, risks plunge in share price
Author:Laurel Henning

In Brief

US photocopier maker Xerox has forgone a reprieve from its legal battle with activist investors Carl Icahn and Darwin Deason, choosing instead to fight tooth and nail to protect its current board and the company's merger plans with Fujifilm Holdings. Its decision has put in motion what will likely be a prolonged legal battle, causing uncertainty among investors and pushing down share prices.

We use Cookies to deliver our online, application, and email services. Details on the cookies we use and instructions on how to disable them are set out in our Cookie Policy
© 2018 MLex Ltd. All rights reserved. | Terms | Cookie Policy | Privacy Policy | Supported Devices and Browsers
MLex is the primary resource for exclusive market insight, analysis and commentary to finance, investment and legal professionals.